DADr. Agarwals Health Care544350Earnings release date

Board meeting on November 05, 2026 to approve September quarter results; analyst call same day

Board meeting on Thursday, November 05, 2026 to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026.

By ScoutQuest · Fri 23 Oct 2026, 5:40 PM IST · 2 min read

Board Meeting Date

Thursday, November 05, 2026

Period Covered

quarter and half year ended September 30, 2026

Analyst Call Timing

November 05, 2026, from 06:30 PM IST to 07:30 PM IST

This intimation gives two dates-in-one: when the board will approve the September 2026 quarter numbers, and when management will speak to investors about them.

What the board meeting covers

• The Board of Directors is scheduled to meet on Thursday, November 05, 2026.
• The agenda item stated is to consider and approve the Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026.

The earnings / analyst conference call

• Held on the same day, November 05, 2026, from 06:30 PM IST to 07:30 PM IST.
• The company will be represented by Dr. Adil Agarwal (Whole-time Director and Chief Executive Officer), Mr. Yashwanth Venkat (Chief Financial Officer) and Ms. Aashna Dharia (Head, Investor Relations).
• India dial-in lines given are +91 22 6280 1308 and +91 22 7115 8161, along with international toll-free numbers for several countries; participants are asked to dial in 10 minutes before the scheduled start.

Trading window

• In terms of the company's Code of Conduct for Prevention of Insider Trading, the trading window will remain closed until 48 hours after the announcement of the financial results.

How to read this for a retail shareholder

• This is a scheduling notice. It tells you the date the numbers will be approved and made public, not what the numbers are.
• The results themselves are what carry the financial detail: revenue, profitability and segment performance for the quarter and half year ended September 30, 2026.
• The conference call is the forum where management typically answers analyst and investor questions on those results; the dial-in details are in the notice for anyone who wants to listen in.
• The trading window restriction applies to designated persons covered by the company's insider trading code and is a standard feature around results announcements.

The perception this can create is one of a routine, scheduled disclosure: the company has fixed a date for its quarterly results and arranged an investor call for the same evening.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev